MicroRx, a division of CSU Ventures, Inc., provides solutions for global health needs through strategic partnering with industry, investors, government agencies, non-profit organizations and the public to rapidly develop products emerging from Colorado State University’s world-class infectious disease research.  
     
  We believe that rapidly moving products to market is the most effective way to leverage university research for the benefit of humankind.  
     
News and Events
  12.28.2009 - Engineering researcher exploring portable method for detecting tuberculosis
  10.05.2009 - Discoveries of flaws in tuberculosis research system earns professor an award for innovation
  09.01.2009 - CSU to host drug discovery, research program funded by $2.25 million grant
  07.28.2009 - Foreign mosquitoes invading United States
  07.24.2009 - RIC-GMP Building Request for Information
  05.27.2009 - TB Alliance Announces Drug Discovery Collaboration with CSU
   
 
The CSU Research Innovation Center will open its doors to research on March 31st, 2010. Learn more...
   
Opening:
 
     
 
Copyright © 2007 MicroRx. All rights reserved.
 
MicroRx Colorado State University